{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T10:09:42Z","timestamp":1781690982377,"version":"3.54.5"},"reference-count":39,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,2,14]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Multiplexing antibodies against common human epitopes all labeled with the same fluorophore facilitates optical imaging of heterogenous AML. Multiplexing fluorescently labeled monoclonal antibodies permits optical imaging of primary patient xenograft pathology\/therapy response.<\/jats:p>","DOI":"10.1182\/blood-2012-05-429555","type":"journal-article","created":{"date-parts":[[2012,12,13]],"date-time":"2012-12-13T20:59:49Z","timestamp":1355432389000},"page":"e34-e42","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":16,"title":["Multiplexed mAbs: a new strategy in preclinical time-domain imaging of acute myeloid leukemia"],"prefix":"10.1182","volume":"121","author":[{"given":"Emmet","family":"McCormack","sequence":"first","affiliation":[{"name":"Institute of Medicine, Hematology Section, University of Bergen, Bergen, Norway;"},{"name":"Department of Internal Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Muji\u0107","sequence":"additional","affiliation":[{"name":"Institute of Medicine, Hematology Section, University of Bergen, Bergen, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tereza","family":"Osdal","sequence":"additional","affiliation":[{"name":"Institute of Medicine, Hematology Section, University of Bergen, Bergen, Norway;"},{"name":"KinN Therapeutics AS, Haukeland University Hospital, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8ystein","family":"Bruserud","sequence":"additional","affiliation":[{"name":"Institute of Medicine, Hematology Section, University of Bergen, Bergen, Norway;"},{"name":"Department of Internal Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn Tore","family":"Gjertsen","sequence":"additional","affiliation":[{"name":"Institute of Medicine, Hematology Section, University of Bergen, Bergen, Norway;"},{"name":"Department of Internal Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"20","key":"2019111816502726700_B1","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1200\/JCO.2010.32.8500","article-title":"Long-term prognosis of acute myeloid leukemia according to the new genetic risk classification of the European LeukemiaNet recommendations: evaluation of the proposed reporting system.","volume":"29","author":"Rollig","year":"2011","journal-title":"J Clin Oncol"},{"issue":"5","key":"2019111816502726700_B2","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1365-2141.2010.08470.x","article-title":"Acute myeloid leukaemia in the elderly: a review.","volume":"152","author":"Pollyea","year":"2011","journal-title":"Br J Haematol"},{"issue":"2","key":"2019111816502726700_B3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/MOH.0b013e3283500a92","article-title":"New induction and postinduction strategies in acute myeloid leukemia.","volume":"19","author":"Burnett","year":"2012","journal-title":"Curr Opin Hematol"},{"issue":"5","key":"2019111816502726700_B4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1200\/JCO.2010.30.1820","article-title":"Therapeutic advances in acute myeloid leukemia.","volume":"29","author":"Burnett","year":"2011","journal-title":"J Clin Oncol"},{"issue":"5","key":"2019111816502726700_B5","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/sj.leu.2403670","article-title":"Animal models of acute myelogenous leukaemia - development, application and future perspectives.","volume":"19","author":"McCormack","year":"2005","journal-title":"Leukemia"},{"issue":"27","key":"2019111816502726700_B6","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1038\/onc.2008.16","article-title":"Review: genetic models of acute myeloid leukaemia.","volume":"27","author":"McCormack","year":"2008","journal-title":"Oncogene"},{"issue":"3","key":"2019111816502726700_B7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nrd3385","article-title":"Advances in the preclinical testing of cancer therapeutic hypotheses.","volume":"10","author":"Caponigro","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"2019111816502726700_B8","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.4161\/cbt.213","article-title":"Human tumor xenografts as predictive preclinical models for anticancer drug activity in humans: better than commonly perceived-but they can be improved.","volume":"2","author":"Kerbel","year":"2003","journal-title":"Cancer Biol Ther"},{"issue":"6","key":"2019111816502726700_B9","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.ejca.2004.01.003","article-title":"Integrating pharmacology and in vivo cancer models in preclinical and clinical drug development.","volume":"40","author":"Peterson","year":"2004","journal-title":"Eur J Cancer"},{"issue":"3","key":"2019111816502726700_B10","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1182\/blood-2005-06-2325","article-title":"AML engraftment in the NOD\/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML.","volume":"107","author":"Pearce","year":"2006","journal-title":"Blood"},{"issue":"7","key":"2019111816502726700_B11","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrd2290","article-title":"Molecular imaging in drug development.","volume":"7","author":"Willmann","year":"2008","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"2019111816502726700_B12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2310\/7290.2007.00016","article-title":"In vivo optical imaging of acute myeloid leukemia by green fluorescent protein: time-domain autofluorescence decoupling, fluorophore quantification, and localization.","volume":"6","author":"McCormack","year":"2007","journal-title":"Mol Imaging"},{"issue":"5","key":"2019111816502726700_B13","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/leu.2011.315","article-title":"Synergistic induction of p53 mediated apoptosis by valproic acid and nutlin-3 in acute myeloid leukemia.","volume":"26","author":"McCormack","year":"2012","journal-title":"Leukemia"},{"issue":"8","key":"2019111816502726700_B14","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/leu.2008.118","article-title":"Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16.","volume":"22","author":"Modlich","year":"2008","journal-title":"Leukemia"},{"issue":"4","key":"2019111816502726700_B15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/MOH.0b013e3281900f01","article-title":"Insertional mutagenesis in gene therapy and stem cell biology.","volume":"14","author":"Baum","year":"2007","journal-title":"Curr Opin Hematol"},{"issue":"3","key":"2019111816502726700_B16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1053\/j.semnuclmed.2009.12.005","article-title":"Antibody vectors for imaging.","volume":"40","author":"Olafsen","year":"2010","journal-title":"Semin Nucl Med"},{"issue":"4","key":"2019111816502726700_B17","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1182\/blood.V85.4.1122.bloodjournal8541122","article-title":"Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation.","volume":"85","author":"Matthews","year":"1995","journal-title":"Blood"},{"issue":"1","key":"2019111816502726700_B18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jphotobiol.2009.11.007","article-title":"Pre-clinical whole-body fluorescence imaging: Review of instruments, methods and applications.","volume":"98","author":"Leblond","year":"2010","journal-title":"J Photochem Photobiol B"},{"issue":"8","key":"2019111816502726700_B19","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1593\/neo.09662","article-title":"Increased plasma colloid osmotic pressure facilitates the uptake of therapeutic macromolecules in a xenograft tumor model.","volume":"11","author":"Hofmann","year":"2009","journal-title":"Neoplasia"},{"issue":"1","key":"2019111816502726700_B20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.leukres.2009.09.005","article-title":"Protein kinase A activators and the pan-PPAR agonist tetradecylthioacetic acid elicit synergistic anti-leukaemic effects in AML through CREB.","volume":"34","author":"Erikstein","year":"2010","journal-title":"Leuk Res"},{"issue":"2","key":"2019111816502726700_B21","doi-asserted-by":"crossref","first-page":"H391","DOI":"10.1152\/ajpheart.00842.2011","article-title":"Minimally invasive quantification of lymph flow in mice and rats by imaging depot clearance of near-infrared albumin.","volume":"302","author":"Karlsen","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"17","key":"2019111816502726700_B22","doi-asserted-by":"crossref","first-page":"17ra9","DOI":"10.1126\/scitranslmed.3000349","article-title":"Identification of therapeutic targets for quiescent, chemotherapy- resistant human leukemia stem cells.","volume":"2","author":"Saito","year":"2010","journal-title":"Sci Transl Med"},{"issue":"11","key":"2019111816502726700_B23","first-page":"629","article-title":"Valproic acid and all-trans retinoic acid: meta-analysis of a palliative treatment regimen in AML and MDS patients.","volume":"31","author":"Bellos","year":"2008","journal-title":"Onkologie"},{"issue":"1","key":"2019111816502726700_B24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1182\/blood-2004-03-1074","article-title":"Retinoids and myelomonocytic growth factors cooperatively activate RARA and induce human myeloid leukemia cell differentiation via MAP kinase pathways.","volume":"105","author":"Glasow","year":"2005","journal-title":"Blood"},{"issue":"3","key":"2019111816502726700_B25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.beha.2010.06.007","article-title":"The role of multiparameter flow cytometry for disease monitoring in AML.","volume":"23","author":"Kern","year":"2010","journal-title":"Best Pract Res Clin Haematol"},{"issue":"14","key":"2019111816502726700_B26","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1158\/1078-0432.CCR-10-0093","article-title":"Dynamic single-cell network profiles in acute myelogenous leukemia are associated with patient response to standard induction therapy.","volume":"16","author":"Kornblau","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2019111816502726700_B27","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cell.2004.06.028","article-title":"Single cell profiling of potentiated phospho-protein networks in cancer cells.","volume":"118","author":"Irish","year":"2004","journal-title":"Cell"},{"issue":"15","key":"2019111816502726700_B28","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1200\/JCO.2005.03.8448","article-title":"Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.","volume":"24","author":"Perik","year":"2006","journal-title":"J Clin Oncol"},{"issue":"12","key":"2019111816502726700_B29","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/MNM.0b013e3283134d6e","article-title":"99mTc-labelled rituximab, a new non-Hodgkin's lymphoma imaging agent: first clinical experience.","volume":"29","author":"Gmeiner Stopar","year":"2008","journal-title":"Nucl Med Commun"},{"issue":"2","key":"2019111816502726700_B30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.canlet.2011.10.017","article-title":"Recent trends in antibody-based oncologic imaging.","volume":"315","author":"Kaur","year":"2012","journal-title":"Cancer Lett"},{"issue":"17","key":"2019111816502726700_B31","first-page":"4953","article-title":"In vivo imaging of proteolytic enzyme activity using a novel molecular reporter.","volume":"60","author":"Tung","year":"2000","journal-title":"Cancer Res"},{"issue":"1","key":"2019111816502726700_B32","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1158\/1535-7163.MCT-08-0862","article-title":"In vivo target-specific activatable near-infrared optical labeling of humanized monoclonal antibodies.","volume":"8","author":"Ogawa","year":"2009","journal-title":"Mol Cancer Ther"},{"issue":"9","key":"2019111816502726700_B33","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.2967\/jnumed.111.087619","article-title":"99mTc-Hydrazinonicotinamide epidermal growth factor-polyethylene glycol-quantum dot imaging allows quantification of breast cancer epidermal growth factor receptor expression and monitors receptor downregulation in response to cetuximab therapy.","volume":"52","author":"Jung","year":"2011","journal-title":"J Nucl Med"},{"issue":"6","key":"2019111816502726700_B34","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.molonc.2010.08.003","article-title":"Targeted nanoagents for the detection of cancers.","volume":"4","author":"McCarthy","year":"2010","journal-title":"Mol Oncol"},{"issue":"1","key":"2019111816502726700_B35","doi-asserted-by":"crossref","first-page":"e30690","DOI":"10.1371\/journal.pone.0030690","article-title":"Optical imaging of disseminated leukemia models in mice with near-infrared probe conjugated to a monoclonal antibody.","volume":"7","author":"Pesnel","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"2019111816502726700_B36","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1182\/blood-2011-08-363291","article-title":"Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia.","volume":"119","author":"Buccisano","year":"2012","journal-title":"Blood"},{"issue":"3","key":"2019111816502726700_B37","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.leukres.2010.06.010","article-title":"Early assessment of treatment response in patients with AML using [(18)F]FLT PET imaging.","volume":"35","author":"Vanderhoek","year":"2011","journal-title":"Leuk Res"},{"issue":"11","key":"2019111816502726700_B38","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.2967\/jnumed.108.055335","article-title":"First demonstration of leukemia imaging with the proliferation marker 18F-fluorodeoxythymidine.","volume":"49","author":"Buck","year":"2008","journal-title":"J Nucl Med"},{"issue":"10","key":"2019111816502726700_B39","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/ijc.26318","article-title":"Leukemia stem cells.","volume":"129","author":"Buss","year":"2011","journal-title":"Int J Cancer"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/7\/e34\/1368194\/zh800713000e34.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/7\/e34\/1368194\/zh800713000e34.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T16:50:51Z","timestamp":1574095851000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/121\/7\/e34\/31534\/Multiplexed-mAbs-a-new-strategy-in-preclinical"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,14]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,2,14]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-05-429555","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,14]]}}}